Tom Marino
American politician & attorney (born 1952) / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Tom Marino?
Summarize this article for a 10 year old
Thomas Anthony Marino (born August 13, 1952) is an American politician and attorney, who served as a United States Representative from Pennsylvania from 2011 to 2019. He represented the 10th congressional district from January 3, 2011 to January 3, 2019, and the 12th district from January 3 to January 23, 2019, when he resigned to work in the private sector. A member of the Republican Party, Marino was the United States Attorney for the United States District Court for the Middle District of Pennsylvania in his early career.
Tom Marino | |
---|---|
Member of the U.S. House of Representatives from Pennsylvania | |
In office January 3, 2011 – January 23, 2019 | |
Preceded by | Chris Carney |
Succeeded by | Fred Keller |
Constituency | 10th district (2011–2019) 12th district (2019) |
United States Attorney for the Middle District of Pennsylvania | |
In office 2002 – October 12, 2007 | |
President | George W. Bush |
Preceded by | David Barasch |
Succeeded by | Martin Carlson |
District Attorney of Lycoming County | |
Assumed office December 29, 2023 | |
Preceded by | Ryan C. Gardner |
In office 1992–2002 | |
Preceded by | Brett Feese |
Succeeded by | Michael Dinges |
Personal details | |
Born | Thomas Anthony Marino (1952-08-13) August 13, 1952 (age 71) Williamsport, Pennsylvania, U.S. |
Political party | Republican |
Spouse | Edie |
Children | 2 (adopted) |
Education | Pennsylvania College of Technology Lycoming College (BA) Dickinson School of Law (JD) |
On September 1, 2017, President Donald Trump nominated Marino to be Director of the Office of National Drug Control Policy, commonly known as the "drug czar".[1] He withdrew on October 17, 2017, following reports that he had been the chief architect behind a bill that protected pharmaceutical manufacturers and distributors and crippled the DEA's ability to combat the U.S. opioid epidemic.[2] Two weeks after being sworn in for his fifth term, Marino announced his resignation from Congress, effective January 23, 2019, to work in the private sector.[3]